Evaluating Suspected Tumor Recurrence with Epidermal Growth Factor Receptor-Targeted [(89)Zr]Zr-Panitumumab PET/CT. Hoang J, Golliday K, McAdoo A, Rosenberg A, et al. J Nucl Med 2026 Sep 3:jnumed.125.271333. doi: 10.2967/jnumed.125.271333.

Read + Share

Amedeo Smart

Independent Medical Education

Hoang J, Golliday K, McAdoo A, Rosenberg A, et al. Evaluating Suspected Tumor Recurrence with Epidermal Growth Factor Receptor-Targeted [(89)Zr]Zr-Panitumumab PET/CT. J Nucl Med 2026 Sep 3:jnumed.125.271333. doi: 10.2967/jnumed.125.271333.
PMID: 42692830